These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 33941038

  • 1. The pleiotropic of GLP-1/GLP-1R axis in central nervous system diseases.
    Zhang L, Zhang W, Tian X.
    Int J Neurosci; 2023 May; 133(5):473-491. PubMed ID: 33941038
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic potential of spinal GLP-1 receptor signaling.
    Zhang D, Lv G.
    Peptides; 2018 Mar; 101():89-94. PubMed ID: 29329976
    [Abstract] [Full Text] [Related]

  • 3. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH, Jeon SJ, Cho KS, Moon E, Sapkota A, Jun HS, Ryu JH, Choi JW.
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [Abstract] [Full Text] [Related]

  • 4. Central Nervous System GLP-1 Receptors Regulate Islet Hormone Secretion and Glucose Homeostasis in Male Rats.
    Jessen L, Smith EP, Ulrich-Lai Y, Herman JP, Seeley RJ, Sandoval D, D'Alessio D.
    Endocrinology; 2017 Jul 01; 158(7):2124-2133. PubMed ID: 28430981
    [Abstract] [Full Text] [Related]

  • 5. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.
    Hou Y, Ernst SA, Heidenreich K, Williams JA.
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan 01; 310(1):G26-33. PubMed ID: 26542397
    [Abstract] [Full Text] [Related]

  • 6. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA, Hill ME, Saleh J, Perkins B, Drucker DJ.
    Diabetes; 2000 Sep 01; 49(9):1552-60. PubMed ID: 10969840
    [Abstract] [Full Text] [Related]

  • 7. Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases.
    Chen SD, Chuang YC, Lin TK, Yang JL.
    Eur J Pharmacol; 2023 Jan 05; 938():175439. PubMed ID: 36470445
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.
    Nauck MA, Meier JJ, Cavender MA, Abd El Aziz M, Drucker DJ.
    Circulation; 2017 Aug 29; 136(9):849-870. PubMed ID: 28847797
    [Abstract] [Full Text] [Related]

  • 9. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
    Bueno AB, Showalter AD, Wainscott DB, Stutsman C, Marín A, Ficorilli J, Cabrera O, Willard FS, Sloop KW.
    J Biol Chem; 2016 May 13; 291(20):10700-15. PubMed ID: 26975372
    [Abstract] [Full Text] [Related]

  • 10. Glucagon-like peptide-1 receptor action in the vasculature.
    Almutairi M, Al Batran R, Ussher JR.
    Peptides; 2019 Jan 13; 111():26-32. PubMed ID: 30227157
    [Abstract] [Full Text] [Related]

  • 11. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
    Pederson RA, Satkunarajah M, McIntosh CH, Scrocchi LA, Flamez D, Schuit F, Drucker DJ, Wheeler MB.
    Diabetes; 1998 Jul 13; 47(7):1046-52. PubMed ID: 9648827
    [Abstract] [Full Text] [Related]

  • 12. Ileal interposition reduces blood glucose levels and decreases insulin resistance in a type 2 diabetes mellitus animal model by up-regulating glucagon-like peptide-1 and its receptor.
    Sun X, Zheng M, Song M, Bai R, Cheng S, Xing Y, Yuan H, Wang P.
    Int J Clin Exp Pathol; 2014 Jul 13; 7(7):4136-42. PubMed ID: 25120793
    [Abstract] [Full Text] [Related]

  • 13. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
    Campbell SA, Golec DP, Hubert M, Johnson J, Salamon N, Barr A, MacDonald PE, Philippaert K, Light PE.
    Mol Metab; 2020 Sep 13; 39():101014. PubMed ID: 32413586
    [Abstract] [Full Text] [Related]

  • 14. Sitagliptin improves functional recovery via GLP-1R-induced anti-apoptosis and facilitation of axonal regeneration after spinal cord injury.
    Han W, Li Y, Cheng J, Zhang J, Chen D, Fang M, Xiang G, Wu Y, Zhang H, Xu K, Wang H, Xie L, Xiao J.
    J Cell Mol Med; 2020 Aug 13; 24(15):8687-8702. PubMed ID: 32573108
    [Abstract] [Full Text] [Related]

  • 15. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system.
    Merchenthaler I, Lane M, Shughrue P.
    J Comp Neurol; 1999 Jan 11; 403(2):261-80. PubMed ID: 9886047
    [Abstract] [Full Text] [Related]

  • 16. Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R-dependent glucose homeostasis in vivo.
    Baggio LL, Kim JG, Drucker DJ.
    Diabetes; 2004 Dec 11; 53 Suppl 3():S205-14. PubMed ID: 15561912
    [Abstract] [Full Text] [Related]

  • 17. Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
    Roed SN, Nøhr AC, Wismann P, Iversen H, Bräuner-Osborne H, Knudsen SM, Waldhoer M.
    J Biol Chem; 2015 Jan 09; 290(2):1233-43. PubMed ID: 25451942
    [Abstract] [Full Text] [Related]

  • 18. Acute but not chronic activation of brain glucagon-like peptide-1 receptors enhances glucose-stimulated insulin secretion in mice.
    Tudurí E, Beiroa D, Porteiro B, López M, Diéguez C, Nogueiras R.
    Diabetes Obes Metab; 2015 Aug 09; 17(8):789-99. PubMed ID: 25962313
    [Abstract] [Full Text] [Related]

  • 19. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
    Skow MA, Bergmann NC, Knop FK.
    Diabetes Obes Metab; 2016 Sep 09; 18(9):847-54. PubMed ID: 27160961
    [Abstract] [Full Text] [Related]

  • 20. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
    Lamont BJ, Li Y, Kwan E, Brown TJ, Gaisano H, Drucker DJ.
    J Clin Invest; 2012 Jan 09; 122(1):388-402. PubMed ID: 22182839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.